Sort by
Refine Your Search
-
Listed
-
Field
-
research project on cardiovascular risk prediction for people with immune-mediated inflammatory disease. The successful candidate will use advanced risk prediction methods to develop prediction models
-
. This collaboration of European and American specialist trauma centres aims to advance research in the field of fundamental, translational and clinical research into the body’s acute and longer-term response to severe
-
regression models to complex forms of observational data, and of applying causal inference approaches to health data are essential. Experience of analysing time-to-event outcomes is desirable. This role offers
-
for an enthusiastic and highly motivated Research Fellow to join the world-leading tuberculosis (TB) Modelling group at LSHTM. The successful candidate will be supervised by Dr Rebecca Clark and Prof Richard White and
-
the use of mathematical modelling of infectious diseases. The post-holder will work closely with partners within the Global Polio Eradication Initiative to ensure that research is focused towards supporting
-
delivering professional services within the College’s small animal referral hospital by further developing and delivering advanced cardiac surgical therapies through the open heart surgery programme, at
-
, religion or belief, sexual orientation, or trans status or history. More information on our structures and initiatives around EDI, including information on staff diversity networks, can be found on our
-
health researcher is sought with expertise in quantitative surveys, mathematical modeling in nutrition (especially in Sudan), and crisis clinical nutrition program management. The ideal candidate should
-
clinical endocrinology both paediatric and adult, genetic aspects and gene discovery in endocrine diseases, animal models, stem cells, signalling and cell biology. For further information visit: http
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving